Beyond the PD-1/PD-L1 pathway, emerging evidences show that the BTLA/HVEM pathway (B and T lymphocyte attenuator/herpes virus entry mediator) plays a key role in T cell inhibition in tumor microenvironment [21–24]. The gene discussed is BTLA; the disease is neoplasm.